Drug use in Swedish nursing homes

Clinical Drug Investigation

Volumn 16, Issue 6, 1998, Pages 441-452

  Claesson, Cecilia B ^a,c   Schmidt, Ingrid K ^b,d  

^a NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^b National Corporation of Pharmacies   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; LAXATIVE; PSYCHOTROPIC AGENT;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; NURSING HOME; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SWEDEN; TEAMWORK;

EID: 0032441078     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816060-00004     Document Type: Article

References (48)

1. SCB. Statistisk årsbok. Stockholm: Statistiska Centralbyrån, 1996
2. Schmidt IK, Claesson CB, Westerholm B, et al. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998; 32: 27-32
3. Sandman PO, Wallblom A. Characteristics of the demented living in different settings in Sweden. Acta Neurol Scand Suppl. 1996; 168: 96-100
4. Nordenstam I, Wennberg M, Kristoferson K. Svensk läkemedelsstatistik 1995. Stockholm: Apoteksbolaget, 1996
5. Andersson M. Drugs prescribed for elderly patients in nursing homes or under medical home care. Compr Gerontol [A] 1989; Suppl. A+B 3: 8-15
6. Rørvik FB, Laakke K. Drug prescribing in nursing homes and homes for the aged. J Norweigen Med Assoc 1990; 110: 1335-8
7. Dehlin O, Franzén M. Prevalence of dementia syndromes in persons living in homes for the elderly and in nursing homes in southern Sweden. Scand J Prim Health Care 1985, 3: 215-22
8. Avorn J, Dreyer P, Connelly K, et al. Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of statewide study. N Engl J Med 1989; 320: 227-32
9. Nolan L, O'Malley K. The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age Ageing 1989; 18: 52-6
10. Keltner NL, Folks DG. The omnibus budget reconciliation act: Impact on psychotropic drug use in long-term care facilities. Perspect Psychiatr Care 1995; 31: 30-3
11. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilties. Ann Intern Med 1992; 117: 684-9
12. Kane RL, Williams CC, Kane RA. Restraining restraints: Changes in a standard of care. Annu Rev Public Health 1993; 14: 545-84
13. Laucka PV, Hoffman NB. Decreasing medication use in a nursing-home patient-care unit. Am J Hosp Pharm 1992; 49: 96-9
14. Rovner BW, Edelman BA, Cox MP, et al. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992; 149: 1390-2
15. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994; 271: 358-62
16. Medical Products Agency & The Norwegian Medicines Control Authority. Treatment of mental conditions in patients with dementia. Workshop held in Uppsala, Sweden 1994 Mar. 1995: 1: 9-10
17. Schmidt IK, Claesson CB, Westerholm B, et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. JAGS 1998; 46: 77-82
18. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123: 195-204
19. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. Consultant Pharmacist 1993; 8: 40-7
20. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38: 542-52
21. Soumerai SB, Avorn J. Predictors of physician prescribing change in an educational experiment to improve medication use. Med Care 1987; 25: 210-22
22. Lindberg J, Claesson CB, Cornelius C, et al. Medicine use in the elderly. A population study in an urban area of Sweden. Drug Invest 1994; 8: 241-53
23. Arling G, Ryther BJ, Collins T, et al. Mental illness and psychotropic medication use in the nursing home. J Aging Health 1991; 3: 455-72
24. Beers M, Avorn J. Psychactive medication use in intermediate-care facility residents. JAMA 1988; 260: 3016-20
25. Buck JA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc 1988; 36: 409-18
26. Everitt DE, Fields DR, Soumerai SS, et al. Resident behavior and staff distress in the nursing home. J Am Geriatr Soc 1991; 39: 792-8
27. Burns BJ, Kamerow DB. Psychotropic drug prescriptions for nursing home residents. J Fam Pract 1988; 26: 155-60
28. Beardsley RS. Prescribing of psychotropics in elderly nursing homes patients. J Am Geriatr Soc 1989; 37: 327-30
29. Snowdon J, Vaughan R, Miller R, et al. Psychotropic drug use in Sydney nursing homes. Med J Aust 1995; 163: 70-2
30. Ingman SR, Lawson IR, Pierpaoli PG, et al. A survey of the prescribing and administartion of drugs in a long-term care institution for the elderly. J Am Geriatr Soc 1975; 23: 309-16
31. Ray WA, Federspeil CF, Schaffner W. A study of antipsychotic drug use in nursing homes: epidemiological evidence suggesting misuse. Am J Public Health 1980; 70: 485-91
32. Segal JL, Thompson JF, Floyd RA. Drug utilization and prescribing patterns in a skilled nursing facility: The need for a rational approach to therapeutics. J Am Geriatr Soc 1979; 27: 117-22
33. Billig N, Cohen-Mansfield J, Lipson S. Pharmacological treatment of agitation in a nursing home. J Am Geriatr Soc 1991; 39: 1002-5
34. Sandberg AM. Use of four classes of psychoactive drugs in long-term care facilities. Consultant Pharmacist 1993; 8: 1377-81
35. Bassa R, Law J, Goldberg LA. Hypnotics useage among elderly patients in homes and hospital wards in Salford. Pharm J 1994; 252: 474-6
36. Gilleard CJ, Smits C, Morgan K. Changes in hypnoic usage in residential homes for the elderly: a longitudinal study. Arch Gerontol Geriatr 1984; 3: 223-8
37. Flood D. Hugs not drugs - an alternative management tool. Lamp 1994; 51: 24
38. Lipson S. The restraint-free approach to bahavior problems in the nursing home. Md Med J 1994; 43 (1): 155-7
39. Sinett PF. Restless patients in nursing homes. What is the role of drug therapy? Drugs Aging 1994; 4: 443-8
40. LeSage J. Polypharmacy in geriatric patients. Nurs Clin North Am 1991; 26: 273-90
41. GAO (General Accounting Office) report: prescription drugs and the elderly. Washington: GAO, 1995
42. Manasse HR. Medication use in an imperfect world: drug misadventuring as an issue of policy. Pt 1. Am J Hosp Pharm 1989; 46: 929-44
43. Beard K. Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 1992; 2: 356-67
44. Avorn J, Chen M, Hartley R. Scientific versus commercial ources of influence on prescribing behavior of physicians. Am J Med 1982; 73: 4-8
45. Gulmann NC. Demens og etik. Fra psykofarmaka til livstestamente. Nord Med 1993; 108: 266-8
46. Harrington C, Tompkins C, Curtis M, et al. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 1992; 32: 822-33
47. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for non-scientific prescribing. Soc Sci Med 1989; 28: 577-82
48. Svarstad B, Mount J. Nursing home resources and tranquilizer use among the institionalized elderly. J Am Geriatr Soc 1991; 39: 869-75